- Home
- CBU vs NARI Comparison
CBU vs NARI Comparison
Compare CBU & NARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBU
- NARI
- Stock Information
- Founded
- CBU 1866
- NARI 2011
- Country
- CBU United States
- NARI United States
- Employees
- CBU N/A
- NARI N/A
- Industry
- CBU Major Banks
- NARI Medical/Dental Instruments
- Sector
- CBU Finance
- NARI Health Care
- Exchange
- CBU Nasdaq
- NARI Nasdaq
- Market Cap
- CBU 3.7B
- NARI 4.7B
- IPO Year
- CBU N/A
- NARI 2020
- Fundamental
- Price
- CBU $66.64
- NARI $79.90
- Analyst Decision
- CBU Buy
- NARI Hold
- Analyst Count
- CBU 4
- NARI 12
- Target Price
- CBU $65.75
- NARI $69.22
- AVG Volume (30 Days)
- CBU 237.7K
- NARI 4.8M
- Earning Date
- CBU 01-21-2025
- NARI 02-26-2025
- Dividend Yield
- CBU 2.85%
- NARI N/A
- EPS Growth
- CBU 40.41
- NARI N/A
- EPS
- CBU 3.44
- NARI N/A
- Revenue
- CBU $723,530,000.00
- NARI $574,498,000.00
- Revenue This Year
- CBU N/A
- NARI $24.62
- Revenue Next Year
- CBU $9.95
- NARI $18.00
- P/E Ratio
- CBU $18.72
- NARI N/A
- Revenue Growth
- CBU 12.93
- NARI 22.41
- 52 Week Low
- CBU $41.50
- NARI $36.73
- 52 Week High
- CBU $73.39
- NARI $79.89
- Technical
- Relative Strength Index (RSI)
- CBU 60.21
- NARI 80.06
- Support Level
- CBU $63.14
- NARI $79.60
- Resistance Level
- CBU $66.47
- NARI $79.76
- Average True Range (ATR)
- CBU 1.60
- NARI 0.18
- MACD
- CBU 0.35
- NARI -0.79
- Stochastic Oscillator
- CBU 93.33
- NARI 93.33
About CBU Community Bank System Inc.
Community Financial System Inc is a diversified financial services company that is focused on four main business lines banking, benefits administration, insurance services and wealth management. The Company also offers comprehensive financial planning, trust administration and wealth management services through its Community Bank Wealth Management operating unit. Key revenue is generated from banking business.
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.